Emergence of a prominent myeloid clone in a ZNF384 ‐rearranged B‐cell precursor acute lymphoblastic leukaemia post‐corticosteroid pre‐phase therapy

The authors declare that there is no conflict of interest. The data that support the findings of this study are available on reasonable request from the corresponding author. Supporting Informatioin Supplementary Figure S1A-D, Immunophenotype of blasts by flow cytometry at diagnosis (CD19pos CD10dimpos CD34pos CD33pos CD13dim CD15neg CyCD79apos CyCD22pos). The blasts were also positive for HLA-DR, CD38, CD81 and CD86; and were negative for CD20,...